The immunophenotypic characteristics and flow cytometric scoring system of acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1

Subtype-specific patterns of molecular mutations in acute myeloid leukemia

(2016) D Rose et al.   LEUKEMIA

Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial

(2015) C. Willekens et al.   HAEMATOLOGICA

Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial

(2015) C. Willekens et al.   HAEMATOLOGICA

In adults with t(8;21)AML, posttransplant RUNX1/RUNX1T1-based MRD monitoring, rather than c-KIT mutations, allows further risk stratification

(2014) Y. Wang et al.   BLOOD

Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations

(2014) J.-B. Micol et al.   BLOOD

Minimal residual disease monitored after induction therapy by RQ-PCR can contribute to tailor treatment of patients with t(8;21) RUNX1-RUNX1T1 rearrangement

(2014) M. Pigazzi et al.   HAEMATOLOGICA

High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome

(2014) M-T Krauth et al.   LEUKEMIA

Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients

(2014) R Kihara et al.   LEUKEMIA

Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization

(2013) Sandra Heesch et al.   ANNALS OF HEMATOLOGY

MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial

(2013) H.-H. Zhu et al.   BLOOD

A threshold of 10% for myeloperoxidase by flow cytometry is valid to classify acute leukemia of ambiguous and myeloid origin

(2013) Willemijn van den Ancker et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Effects of c-KIT mutations on expression of the RUNX1/RUNX1T1 fusion transcript in t(8;21)-positive acute myeloid leukemia patients

(2013) Sang Hyuk Park et al.   LEUKEMIA RESEARCH

KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement

(2012) Hee-Jin Kim et al.   ANNALS OF HEMATOLOGY

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes

(2012) J J M van Dongen et al.   LEUKEMIA

Clinical significance of minimal residual disease detected by multidimensional flow cytometry: Serial monitoring after allogeneic stem cell transplantation for acute leukemia

(2012) Takuya Miyazaki et al.   LEUKEMIA RESEARCH

Acute Myeloid Leukemia with the t(8;21) Translocation: Clinical Consequences and Biological Implications

(2011) Håkon Reikvam et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

(2011) Roland B. Walter et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia

(2011) Irena Djunic et al.   MEDICAL ONCOLOGY

Flow Cytometry Rapidly Identifies All Acute Promyelocytic Leukemias With High Specificity Independent of Underlying Cytogenetic Abnormalities

(2010) Henry Y. Dong et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Surrogate marker profiles for genetic lesions in acute leukemias

(2010) Elisabeth Paietta   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

The role of multiparameter flow cytometry for disease monitoring in AML

(2010) Wolfgang Kern et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens

(2010) P. Montesinos et al.   BLOOD

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia

(2010) F. Buccisano et al.   BLOOD

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

(2010) D. Grimwade et al.   BLOOD

Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China

(2009) Y Cheng et al.   LEUKEMIA

Flow cytometric immunophenotyping for hematologic neoplasms

(2008) F. E. Craig et al.   BLOOD